Cited by 1,345Liver physiology and pathologyNF-κB Signaling PathwaysHepatocellular Carcinoma Treatment and Prognosis

The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

Open access

Luedde, Tom, Schwabe, Robert F.·2011·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/nrgastro.2010.213PMC PMC3295539

Open this paper in CoChat — free account

Abstract

Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrgastro.2010.213

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047

Show all 137 references

Sorted by citations

Items 401–500 of 999

New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article
Ebrahimi, H., Naderian, M., & Sohrabpour, A. A. (2018) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2018.103 · Cited by 41
Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway
Al‐Massri, K. F., Ahmed, L. A., & El-Abhar, H. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.013 · Cited by 38
Pectin oligosaccharide from hawthorn fruit ameliorates hepatic inflammation via NF-κB inactivation in high-fat diet fed mice
Li, T., Chen, X., Huang, Z., Xie, W., Tong, C., Bao, R., Sun, X., Li, W., & Li, S. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.027 · Cited by 38
Theranostic Quercetin Nanoparticle for Treatment of Hepatic Fibrosis
Zhang, Q., Xu, D., Guo, Q., Shan, W., Yang, J., Lin, T., Ye, S., Zhou, X., Ge, Y., Bi, S., et al. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00631 · Cited by 38
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
Scarpellini, E., Fagoonee, S., Rinninella, E., Rasetti, C., Aquila, I., Larussa, T., Ricci, P., Luzza, F., & Abenavoli, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082488 · Cited by 39
Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis
Liang, J., Zhang, B., Shen, R., Liu, J., Gao, M., Li, Y., Li, Y., & Zhang, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082232 · Cited by 38
Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression
MacParland, S. A., Ma, X., Chen, L., Khattar, R., Cherepanov, V., Selzner, M., Feld, J. J., Selzner, N., & McGilvray, I. D. (2016) · Journal of Virology · doi:10.1128/jvi.02557-15 · Cited by 38
Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout
Ehlken, H., Krishna-Subramanian, S., Ochoa‐Callejero, L., Kondylis, V., Nadi, N. E., Straub, B. K., Schirmacher, P., Walczak, H., Kollias, G. A., & Pasparakis, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.83 · Cited by 37
Abscisic acid ameliorates oxidative stress, inflammation, and apoptosis in thioacetamide-induced hepatic fibrosis by regulating the NF-кB signaling pathway in mice
Chen, X., Ding, C., Liu, W., Liu, X., Zhao, Y., Zheng, Y., Dong, L., Khatoon, S., Hao, M., Peng, X., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173652 · Cited by 37
Synergistic anti-liver cancer effects of curcumin and total ginsenosides
Deng, Z., Xu, X., Yunita, F., Zhou, Q., Wu, Y., Hu, Y., Wang, Z., & Tian, X. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i10.1091 · Cited by 37
An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms
Zhao, Q., Bai, J., Chen, Y., Liu, X., Zhao, S., Ling, G., Jia, S., Zhai, F., & Xiang, R. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115567 · Cited by 41
Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Borralho, P. M., Rodrigues, C. M. P., & Castro, R. E. (2015) · Scientific Reports · doi:10.1038/srep17528 · Cited by 37
IL-33 Provides Neuroprotection through Suppressing Apoptotic, Autophagic and NF-κB-Mediated Inflammatory Pathways in a Rat Model of Recurrent Neonatal Seizure
Gao, Y. Z., Luo, C., Li, L., Ye, G.-H., Gao, C. H., Wang, H., Huang, W., Wang, T., Wang, Z., Ni, H., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00423 · Cited by 37
Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation
Sharma, R., Jadhav, M., Choudhary, N., Kumar, A., Rauf, A., Gundamaraju, R., Alasmari, A. F., Ali, N., Singla, R. K., Sharma, R., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1063118 · Cited by 36
Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals
Mobasheri, L., Ahadi, M., Namdar, A. B., Alavi, M. S., Bemidinezhad, A., Farahi, S. M. M., Esmaeilizadeh, M., Nikpasand, N., Einafshar, E., & Ghorbani, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115502 · Cited by 41
Role of Kynurenine and Its Derivatives in Liver Diseases: Recent Advances and Future Clinical Perspectives
Tan, Q., Deng, S., & Xiong, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030968 · Cited by 42
Aspartame increases the risk of liver cancer through CASP1 protein: A comprehensive network analysis insights
Li, N.-R., Zeng, Y., Gu, Y.-F., Xie, P., Deng, B., Lu, S. W., Li, W.-A., & Liu, Y. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118089 · Cited by 39
New advances and potentials of fungal immunomodulatory proteins for therapeutic purposes
Ejike, U. C., Chan, C. J., Okechukwu, P. N., & Lim, R. L. H. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1808581 · Cited by 39
c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis
Leslie, J., Macia, M. G., Luli, S., Worrell, J. C., Reilly, W. J., Paish, H. L., Knox, A., Barksby, B. S., Gee, L., Zaki, M. Y. W., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00306-2 · Cited by 36
Self-citation
Bifidobacterium longum BL-10 with Antioxidant Capacity Ameliorates Lipopolysaccharide-Induced Acute Liver Injury in Mice by the Nuclear Factor-κB Pathway
Dong, J., Ping, L., Meng, Y., Zhang, K., Tang, H., Liu, D., Li, B., & Huo, G. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02950 · Cited by 36
Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances
Ding, Z., Wang, L., Sun, J., Zheng, L., Tang, Y., & Tang, H. H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1526206 · Cited by 35
Hepatoprotective effects of Micromeria croatica ethanolic extract against CCl4–induced liver injury in mice
Vladimir‐Knežević, S., Cvijanović, O., Blažeković, B., Kindl, M., Štefan, M. B., & Domitrović, R. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0763-8 · Cited by 35
AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma
Cui, Y., Lin, C., Wu, Z., Liu, A., Zhang, X., Zhu, J., Wu, G., Wu, J., Li, M., Li, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2666 · Cited by 35
High-throughput metabolomics approach reveals new mechanistic insights for drug response of phenotypes of geniposide towards alcohol-induced liver injury by using liquid chromatography coupled to high resolution mass spectrometry
Zhang, T., Zhang, A., Qiu, S., Sun, H. J., Han, Y., Guan, Y., & Wang, X. (2016) · Molecular BioSystems · doi:10.1039/c6mb00742b · Cited by 35
Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling
Urlep, Ž., Lorbek, G., Perše, M., Jeruc, J., Juvan, P., Matz‐Soja, M., Gebhardt, R., Björkhem, I., Hall, J. A., Bonneau, R., et al. (2017) · Scientific Reports · doi:10.1038/srep40775 · Cited by 33
Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl 4 -induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling
Sun, H., Chen, G., Wen, B., Sun, J., An, H., Pang, J., Xu, W. G., Yang, X.-M., & Songqi, H. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.01.003 · Cited by 35
Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis
Gharbia, S., Baltă, C., Herman, H., Roșu, M., Váradi, J., Bácskay, I., Vecsernyés, M., Gyöngyösi, S., Fenyvesi, F., Voicu, S. N., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00883 · Cited by 35
Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis
Dash, S., Aydın, Y., & Wu, T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.015 · Cited by 36
Prohibitin 1 in liver injury and cancer
Barbier‐Torres, L., & Lu, S. C.-L. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220908257 · Cited by 35
NF-κB Regulation by Gut Microbiota Decides Homeostasis or Disease Outcome During Ageing
Zhang, S., Paul, S., & Kundu, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.874940 · Cited by 40
Cystathionine γ-Lyase Deficiency Exacerbates CCl 4 -Induced Acute Hepatitis and Fibrosis in the Mouse Liver
Ci, L., Yang, X., Gu, X., Li, Q., Guo, Y., Zhou, Z., Zhang, M., Shi, J., Yang, H., Wang, Z., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6773 · Cited by 35
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
Manilla, V., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15112521 · Cited by 37
The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer
Grisetti, L., Garcia, C. J. C., Saponaro, A. A., Tiribelli, C., & Pascut, D. (2024) · Cell Proliferation · doi:10.1111/cpr.13641 · Cited by 34
Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease
Lyu, Y., Yang, X., Yang, L., Dai, J., Qin, H., Zhou, Y., Huang, Y., Wang, Y., Wu, D., Shuai, Q., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.011 · Cited by 37
Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats
Zhao, S., Li, N., Zhen, Y., Ge, M., Li, Y., Yu, B., He, H., & Shao, R. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.10.010 · Cited by 34
Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis
Van, T.-M., Polykratis, A., Straub, B. K., Kondylis, V., Papadopoulou, N., & Pasparakis, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92508 · Cited by 35
Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2
Wang, Y., Zhu, H., Li, H., Li, Y., Zhao, B., & Jin, Y. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.04.002 · Cited by 34
Hepatoprotective Principles and Other Chemical Constituents from the Mycelium of Phellinus linteus
Huang, S.-C., Wang, P.-W., Kuo, P., Hung, H., & Pan, T. (2018) · Molecules · doi:10.3390/molecules23071705 · Cited by 34
Stevia rebaudianatea prevents experimental cirrhosis via regulation of NF‐κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activation
Ramos‐Tovar, E., Flores‐Beltrán, R. E., Galindo‐Gómez, S., Vera‐Aguilar, E., Dı́az-Ruiz, A., Montes, S., Camacho, J., Tsutsumi, V., & Muriel, P. (2018) · Phytotherapy Research · doi:10.1002/ptr.6197 · Cited by 34
Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease
Huh, J. Y., & Saltiel, A. R. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00712-w · Cited by 39
hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p/KAT2B
Ma, J., Li, Y., Chen, M., Wang, W., Zhao, Q., He, B., Zhang, M., & Jiang, Y. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09714-4 · Cited by 37
Role of NLRC5 in progression and reversal of hepatic fibrosis
Liu, X., Wu, Y., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.012 · Cited by 32
Cell therapy in end-stage liver disease: replace and remodel
Hu, X.-H., Chen, L., Wu, H., Tang, Y., Zheng, Q.-M., Wei, X., Wei, Q., Huang, Q., Chen, J., & Xu, X. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03370-z · Cited by 38
Advances in the Study of Selenium‐Enriched Probiotics: From the Inorganic Se into Se Nanoparticles
Xiao, D., Li, T., Huang, X., Zhu, K., Li, Z., Dong, Y., Wang, L., & Huang, J. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300432 · Cited by 34
ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway
Ji, Y., Ni, C., Shen, Y., Xu, Z., Tang, L., Yu, F., Zhu, L., Lu, H., Zhang, C., Yang, S., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02056-1 · Cited by 33
Expression and purification of an FGF9 fusion protein in E. coli, and the effects of the FGF9 subfamily on human hepatocellular carcinoma cell proliferation and migration
Wang, S., Lin, H., Zhao, T., Huang, S., Fernig, D. G., Xu, N., Wu, F., Zhou, M., Jiang, C., & Tian, H. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8468-1 · Cited by 33
The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways
Cho, W., Jin, X., Pang, J., Wang, Y., Mivechi, N. F., & Moskophidis, D. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00391-18 · Cited by 33
Mangiferin improves hepatic damage-associated molecular patterns, lipid metabolic disorder and mitochondrial dysfunction in alcohol hepatitis rats
Li, M., Wu, C., Guo, H., Chu, C., Hu, M., & Zhou, C. (2019) · Food & Function · doi:10.1039/c9fo00153k · Cited by 32
Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort
Tang, K., Dufour, J., Chen, P., Hernáez, R., & Hutfless, S. M. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000349 · Cited by 33
An Experimental DUAL Model of Advanced Liver Damage
Benedé‐Ubieto, R., Estévez‐Vázquez, O., Guo, F., Chen, C., Singh, Y., Nakaya, H. I., del Moral, M. G., Lamas‐Paz, A., Morán, L., López‐Alcántara, N., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1698 · Cited by 34
Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
Vulf, M. A., Skuratovskaia, D., Komar, A., Bograya, M., Затолокин, П. А., Кириенкова, Е. В., Газатова, Н. Д., Kozlov, I. G., & Litvinova, L. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.736677 · Cited by 34
Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways
El-Hanboshy, S. M., Helmy, M. W., & Abd-Alhaseeb, M. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06715-0 · Cited by 32
Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR
Wang, R., Li, S., Chen, P., Yue, X., Wang, S., Gu, Y., & Yuan, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154435 · Cited by 33
Morin, a dietary flavonoid, exhibits anti-fibrotic effect and induces apoptosis of activated hepatic stellate cells by suppressing canonical NF-κB signaling
MadanKumar, P., Perumal, N., Devaraj, H., & NiranjaliDevaraj, S. (2015) · Biochimie · doi:10.1016/j.biochi.2015.01.002 · Cited by 33
Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway
Lu, Y., Zhao, X., Xu, X. M., Piao, J. S., Aosai, F., Li, Y.-B., Shen, L.-X., Su-yun, S., Xu, G., Ma, J., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106539 · Cited by 33
Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus
Liu, Y., Wang, D., & Yang, L. (2022) · Current Drug Targets · doi:10.2174/1389450123666220429082702 · Cited by 35
ROS in hepatocellular carcinoma: What we know
Xing, L., Tang, Y., Li, L., & Tao, X. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109699 · Cited by 34
Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice
Jia, D., Duan, F., Peng, P., Sun, L., Liu, X., Wang, L., Wu, W., Ruan, Y., & Gu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060115 · Cited by 31
miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.
Liu, Z., Wang, C., Jiao, X., Zhao, S., Liu, X., Wang, Y., & Zhang, J. (2016) · PubMed Central · Cited by 32
Screening for the protective effect target of deproteinized extract of calf blood and its mechanisms in mice with CCl4-induced acute liver injury
Xu, G., Han, X., Yuan, G., An, L., & Du, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180899 · Cited by 32
Anti-inflammatory and anti-hyperalgesic effects of milnacipran in inflamed rats: involvement of myeloperoxidase activity, cytokines and oxidative/nitrosative stress
Haddadi, R., & Rashtiani, R. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00726-2 · Cited by 32
Formononetin protects against concanavalin-A-induced autoimmune hepatitis in mice through its anti-apoptotic and anti-inflammatory properties
Liu, G., Zhao, W., Bai, J., Cui, J., Liang, H., & Lu, B. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0197 · Cited by 32
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance
Xia, S., Ji, L., Tao, L., Pan, Y., Lin, Z., Wan, Z., Pan, H., Zhao, J., Cai, L., Xu, J., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.016 · Cited by 32
Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury
Ebrahim, H. A., Kamar, S. S., Haidara, M. A., Latif, N. S. A., Ellatif, M. E. A., ShamsEldeen, A. M., Al‐Ani, B., & Dawood, A. F. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02264-w · Cited by 32
Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH
Lee, S., Kim, S., Choi, I., Song, Y., Kim, N., Ryu, H. C., Lim, J. W., Kang, H. J., Kim, J., & Seo, H. R. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05452-x · Cited by 36
Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases
Upadya, M. H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i11.2913 · Cited by 32
15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury
Lu, Y., Chen, W., Song, K., Han, C. L., Gandhi, C. R., Lim, K., & Wu, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176106 · Cited by 32
CCR5 and inflammatory storm
Lin, Y., Liu, S., Sun, Y., Chen, C., Yang, S., Pei, G., Lin, M., Yu, J., Liu, X., Wang, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102286 · Cited by 33
Umbelliferon-α-d-glucopyranosyl-(2I→ 1II)-α-Dglucopyranoside ameliorates Diethylnitrosamine induced precancerous lesion development in liver via regulation of inflammation, hyperproliferation and antioxidant at pre-clinical stage
Kumar, V., Bhatt, P. C., Rahman, M., Al-Abbasi, F. A., Anwar, F., & Verma, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.047 · Cited by 31
Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma
Wu, M., Miao, H., Fu, R., Zhang, J., & Zheng, W. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200224102820 · Cited by 31
Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development
Wang, Q., Tang, Q., Zhao, L., Zhang, Q., Wu, Y., Hu, H., Liu, L., Liu, X., Zhu, Y., Guo, A., et al. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0335 · Cited by 31
Cantharidin‐induced acute hepatotoxicity: the role of TNF‐α, IKK‐α, Bcl‐2, Bax and caspase3
Yu, Y., Zhang, Y., Zhang, J., Guan, C., Liu, L., & Ren, L. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4003 · Cited by 31
Early Multiplexed Detection of Cirrhosis using Giant Magnetoresistive Biosensors with Protein Biomarkers
Ng, E., Le, A. K., Nguyen, M. H., & Wang, S. X. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00232 · Cited by 31
Chlorogenic Acid Protects against Advanced Alcoholic Steatohepatitis in Rats via Modulation of Redox Homeostasis, Inflammation, and Lipogenesis
Buko, V., Zavodnik, I. B., Budryn, G., Zakłos‐Szyda, M., Belonovskaya, E., Kirko, S. N., Żyżelewicz, D., Zakrzeska, A., Bakunovich, A. А., Rusin, V., et al. (2021) · Nutrients · doi:10.3390/nu13114155 · Cited by 31
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship
Manilla, V., Tommaso, N. D., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Microorganisms · doi:10.3390/microorganisms11020267 · Cited by 32
Artemisia ordosica polysaccharide ameliorated LPS-induced growth inhibition and intestinal injury in broilers through enhancing immune-regulation and antioxidant capacity
Xing, Y., Zheng, Y., Yang, S., Zhang, L., Guo, S., Shi, L., Xu, Y., Jin, X., Yan, S., & Shi, B. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109284 · Cited by 31
The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
Hu, S., Luo, Q., Cun, B., Hu, D., Ge, S., Fan, X., & Chen, F. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131215653 · Cited by 31
D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress
Zhao, S., Li, N., Zhao, W., Liu, H., Ge, M., Zhang, Y., Zhao, L.-Y., You, X., He, H., & Shao, R. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.98 · Cited by 31
Adeno-Associated Virus Serotype 2 Vector–Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis
Brandon‐Warner, E., Benbow, J. H., Swet, J. H., Feilen, N. A., Culberson, C. R., McKillop, I. H., deLemos, A. S., Russo, M. W., & Schrum, L. W. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.035 · Cited by 30
HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice
Afaloniati, H., Angelopoulou, K., Giakoustidis, A. E., Hardas, A., Pseftogas, A., Makedou, K., Gargavanis, A. A., Goulopoulos, T., Iliadis, S., Papadopoulos, V. N., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s250233 · Cited by 30
Rebaudioside A administration prevents experimental liver fibrosis: an in vivo and in vitro study of the mechanisms of action involved
Casas‐Grajales, S., Reyes‐Gordillo, K., Cerda-García-Rojas, C. M., Tsutsumi, V., Lakshman, M., & Muriel, P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3797 · Cited by 30
Regulation of Acetylation States by Nutrients in the Inhibition of Vascular Inflammation and Atherosclerosis
Kang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119338 · Cited by 29
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
Kurahashi, T., Yoshida, Y., Ogura, S., Egawa, M., Furuta, K., Hikita, H., Kodama, T., Sakamori, R., Kiso, S., Kamada, Y., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.10.008 · Cited by 29
Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin‐induced liver fibrosis and biliary fibrosis in mice
Zhou, Z., Qi, J., Zhao, J., Lim, C. W., Kim, J., & Kim, B. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14817 · Cited by 31
Alteration of Gut Microbiota and Its Impact on Immune Response in Patients with Chronic HBV Infection: A Review
Kassa, Y., Million, Y., Gedefie, A., & Moges, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s305901 · Cited by 29
Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis
Wang, S., Tang, C. W., Zhao, H., Shen, P., Lin, C., Zhu, Y., & Han, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.656115 · Cited by 29
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4
Kim, M.-J., Choi, B., Kim, J. Y., Min, Y., Kwon, D. H., Son, J., Lee, J. S., Lee, J. S., Chun, E., & Lee, K.-Y. (2022) · Translational Oncology · doi:10.1016/j.tranon.2021.101250 · Cited by 28
A narrative review of liver regeneration—from models to molecular basis
Huang, W., Han, N., Du, L., Wang, M., Chen, L., & Tang, H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-5234 · Cited by 29
Sericin “hairpin structure”-based multifunctional anthocyanin nanoencapsulation for remodeling ROS-dependent cutaneous wound healing
Zhang, L., Hao, M., Yao, L., Cheng, X., Wen, Q., Zhang, Z., Yu, J., Wang, J., Xing, D., Zheng, T., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145863 · Cited by 29
A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function
Takata, A., Otsuka, M., Yoshikawa, T., Kishikawa, T., Kudo, Y., Goto, T., Yoshida, H., & Koike, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.034 · Cited by 29
Anti-Fibrotic Effect of Plumbagin on CCl4-Lesioned Rats
Wei, Y., Huang, M., Liu, X., Zhang, Y., Peng, Y. P., Huang, Z., Duan, X.-L., & Zhao, T. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373974 · Cited by 29
The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis
Guilcher, C. L., Garcin, I., Dellis, O., Cauchois, F., Tebbi, A., Doignon, I., Guettier, C., Julien, B., & Tordjmann, T. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.020 · Cited by 29
Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-κB signaling pathway
Li, Y., Xi, Y., Tao, G., Xu, G., Yang, Z., Fu, X., Liang, Y., Qian, J., Cui, Y., & Jiang, T. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106386 · Cited by 29
Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
Iacob, S. A., & Iacob, D. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814209 · Cited by 27
Sinapic acid modulates oxidative stress and metabolic disturbances to attenuate ovarian fibrosis in letrozole‐induced polycystic ovary syndrome SD rats
Lan, H., Dong, Z., Zhang, M., Li, W., Chong, C., Wu, Y., Wang, Z., Liu, J., Liu, Z., Qin, X., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.3973 · Cited by 28
Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia
Li, Y.-L., Zhang, N.-Y., Hu, X., Chen, J., Rao, M., Wu, L., Li, Q.-Y., Zhang, B., Yan, W., & Zhang, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.004 · Cited by 28
Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice
Hoshi, M., Osawa, Y., Nakamoto, K., Morita, N., Yamamoto, Y., Ando, T., Tashita, C., Nabeshima, T., & Saito, K. (2020) · Toxicology · doi:10.1016/j.tox.2020.152458 · Cited by 28
An in vitro assessment of the response of THP‐1 macrophages to varying stiffness of a glycol‐chitosan hydrogel for vocal fold tissue engineering applications
Coburn, P. T., Herbay, A. C., Berrini, M., & Li‐Jessen, N. Y. K. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37125 · Cited by 28
4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation
Yen, I., Tu, Q.-W., Chang, T., Lin, P.-H., Li, Y., & Lee, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111504 · Cited by 28
Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr−/−.Leiden mice without attenuation of steatohepatitis
Álvarez‐Amor, L., Luque‐Sierra, A., Cárdenas, A., López-Bermudo, L., López‐Beas, J., Andújar, E., Pérez-Alegre, M., Gallego‐Durán, R., Varela, L. M., Martín‐Montalvo, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87761-3 · Cited by 28

Authors: Luedde, T., & Schwabe, R. F.
Affiliations: Universitätsklinikum Aachen (DE)
Columbia University Irving Medical Center (US)
Corresponding author: Luedde, Tom
Schwabe, Robert F.
ORCID: Luedde, Tom
Schwabe, Robert F.
Venue: Nature Reviews Gastroenterology & Hepatology
Publisher: Springer Science and Business Media LLC
Published: 2011-02
Volume: 8
Issue: 2
Pages: 108-118
ISSN: 1759-5045 (ISSN-L)
1759-5053
DOI: 10.1038/nrgastro.2010.213
PMC: PMC3295539
OpenAlex: W1976777085
Cited by: 1,345
References: 137
Citations by year: 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
FWCI: 5.65
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Gastroenterology & Hepatology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5u54ca126513-03)
National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
National Cancer Institute (U54 CA126513.)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
National Center for Complementary and Integrative Health (R21AT003878)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords: NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
MeSH terms: Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks